Xilin Zhao2018-10-12T20:01:24+00:00

Xilin Zhao, Ph.D.

Associate Professor of Microbiology, Biochemistry & Molecular Genetics
zhaox5@njms.rutgers.edu   |   View CV
+1-973-854-3366
room W310-F

Overview. Dr. Zhao’s work focuses on how to contain and overcome bacterial resistance to antimicrobial agents.  His early work with Dr. Karl Drlica at PHRI developed the mutant selection window hypothesis into a framework for understanding relationships between antimicrobial concentration and selective enrichment of mutant subpopulations. Such work reveals a fundamental flaw in the way antibiotics have been dosed and calls for 1) antimicrobials to be dosed above the upper (mutant prevention concentration (MPC)) rather than the lower (minimum inhibitory concentration (MIC)) boundary of the selection window and 2) new compounds to be designed/developed to have a very narrow window in order to restrict enrichment of resistant mutant subpopulations. Zhao later shifted his effort to 1) better understanding of general mechanisms of antimicrobial killing, with a special emphasis on the bacterial stress response and programmed cell death, 2) developing new antimicrobials/antimicrobial potentiators and repurposing approved non-antimicrobial drugs for antimicrobial use, 3) reversing antimicrobial resistance with CRISPR-based technology, and 4) mitigating detrimental effects of antimicrobials on gut microbiota and on gut inflammation.

Bacterial stress response. Bacterial tolerance and persistence to antimicrobial treatment pose an alarming threat to human health. Stress-response networks underlie mechanisms of tolerance and persistence, thereby preventing bacteria from being killed by many antimicrobials. By understanding and subsequently perturbing stress responses, Dr. Zhao expects to stimulate the lethal action of both antimicrobial and host immune stresses. He has identified reactive oxygen species (ROS)-mediated post-stress bacterial programmed cell death (PCD) as a universal killing mechanism that is shared by many antimicrobial and non-antimicrobial stressors. His work has also identified four factors (MazF, EF4, Cpx, and superoxide) as having dual functions – at moderate levels of stress they protect cells, but at high levels of stress they assure death, largely through a cascade of ROS. Small-molecule inhibitors and enhancers of lethal stress-response factors are expected to both facilitate antimicrobial action and broaden our knowledge of bacterial stress-response networks.

Developing new antimicrobials and repurposing old drugs. With respect to developing new antimicrobials and repurposing old drugs for antimicrobial use, Dr. Zhao has focused on uncovering mechanisms of action of auranofin, gallium nitrate, and bicyclomycin. He has found a handful of compounds that not only synergistically enhance auranofin lethality against Gram-positive bacteria, but they may also help extend the spectrum of auranofin to cover Gram-negative pathogens. In addition, Zhao has identified a way to convert bicyclomycin from a largely static agent to a highly lethal one; with gallium, his laboratory has discovered two molecular targets involved in gallium-mediated bacterial killing. This type of work is expected to help contain multi-drug resistant pathogens.

CRISPR and microbiota. Dr. Zhao has also started an effort to reverse existing antimicrobial resistance by destroying genetic elements that confer antimicrobial resistance using CRISPR-based technology and phage-based delivery. Such work should make it possible to eliminate resistance genes without exerting selective pressure on pathogen populations. He has also been studying the destructive impact of antimicrobial use on gut microbiota and exploring ways to mitigate such detrimental effects on human health.

View all on PubMed

Luan G, Hong Y, Drlica K, Zhao X (2017) Suppression of reactive-oxygen-species accumulation accounts for paradoxical bacterial survival at high quinolone concentration. Antimicrob Agents Chemother. PMI: 29229642

Hong Y, Li L, Luan G, Drlica K, Zhao X (2017) Contribution of reactive oxygen species to thymineless death in Escherichia coli. Nat Microbiol 2: 1667-1675. PMI: 28970486

Chang TL, Tasker C, Subbian S, Gao P, Couret J, Levine C, Ghanny S, Soteropoulos P, Zhao X, Landau N, Lu W (2017) Interferon epsilon protects primary macrophages against HIV infection. J Immunology 198: 158.115. PMI:

Zeng X, Li H, Zheng R, Kurepina N, Kreiswirth BN, Zhao X, Xu Y, Li Q (2016) Spoligotyping of Mycobacterium tuberculosis Complex Isolates by Use of Ligation-Based Amplification and Melting Curve Analysis. J Clin Microbiol 54: 2384-2387. PMI: 27335152

Tasker C, Subbian S, Gao P, Couret J, Levine C, Ghanny S, Soteropoulos P, Zhao X, Landau N, Lu W, Chang TL (2016) IFN-epsilon protects primary macrophages against HIV infection. JCI Insight 1: e88255. PMI: 27942584

Mi H, Wang D, Xue Y, Zhang Z, Niu J, Hong Y, Drlica K, Zhao X (2016) Dimethyl Sulfoxide Protects Escherichia coli from Rapid Antimicrobial-Mediated Killing. Antimicrob Agents Chemother 60: 5054-5058. PMI: 27246776

Malik M, Mustaev A, Schwanz HA, Luan G, Shah N, Oppegard LM, de Souza EC, Hiasa H, Zhao X, Kerns RJ, Drlica K (2016) Suppression of gyrase-mediated resistance by C7 aryl fluoroquinolones. Nucleic Acids Res 44: 3304-3316. PMI: 26984528

Liu Y, Zhou J, Qu Y, Yang X, Shi G, Wang X, Hong Y, Drlica K, Zhao X (2016) Resveratrol Antagonizes Antimicrobial Lethality and Stimulates Recovery of Bacterial Mutants. PLoS One 11: e0153023. PMI: 27045517

Zhao X, Hong Y, Drlica K (2015) Moving forward with reactive oxygen species involvement in antimicrobial lethality. The Journal of antimicrobial chemotherapy 70: 639-642. PMI: Medline:25422287

Long Q, Du Q, Fu T, Drlica K, Zhao X, Xie J (2015) Involvement of Holliday junction resolvase in fluoroquinolone-mediated killing of Mycobacterium smegmatis. Antimicrobial agents and chemotherapy 59: 1782-1785. PMI: Medline:25534729

Zhao X, Malik M, Hong Y, Drlica K (2014) Quinolones. Reference Module in Biomedical Research: 10.1016/B1978-1010-1012-801238-801233.802418-801231. PMI:

Zhao X, Drlica K (2014) Reactive oxygen species and the bacterial response to lethal stress. Current opinion in microbiology 21: 1-6. PMI: Medline:25078317

Yuan X, Liu Y, Bai C, Luo Y, Wang R, Wang R, Cai Y, Zhao X (2014) Mycoplasma pneumoniae infection is associated with subacute cough. The European respiratory journal 43: 1178-1181. PMI: Medline:24232705

Mustaev A, Malik M, Zhao X, Kurepina N, Luan G, Oppegard LM, Hiasa H, Marks KR, Kerns RJ, Berger JM, Drlica K (2014) Fluoroquinolone-gyrase-DNA complexes: two modes of drug binding. The Journal of biological chemistry 289: 12300-12312. PMI: Medline:24497635

Malik M, Li L, Zhao X, Kerns RJ, Berger JM, Drlica K (2014) Lethal synergy involving bicyclomycin: an approach for reviving old antibiotics. The Journal of antimicrobial chemotherapy 69: 3227-3235. PMI: Medline:25085655

Li L, Hong Y, Luan G, Mosel M, Malik M, Drlica K, Zhao X (2014) Ribosomal elongation factor 4 promotes cell death associated with lethal stress. mBio 5: e01708. PMI: Medline:25491353

Mosel M, Li L, Drlica K, Zhao X (2013) Superoxide-mediated protection of Escherichia coli from antimicrobials. Antimicrob Agents Chemother. PMI: 23979754

Dorsey-Oresto A, Lu T, Mosel M, Wang X, Salz T, Drlica K, Zhao X (2013) YihE kinase is a central regulator of programmed cell death in bacteria. Cell Rep 3: 528-537. PMI: 23416055